Forrest, Iain S.
Jaladanki, Suraj K.
Paranjpe, Ishan
Glicksberg, Benjamin S.
Nadkarni, Girish N.
Funding for this research was provided by:
National Institute of General Medical Sciences (T32GM007280, R35GM124836)
National Heart, Lung, and Blood Institute (R01HL155915, R01HL139865)
Article History
Received: 24 February 2021
Accepted: 25 May 2021
First Online: 5 June 2021
Declarations
:
: RD reported receiving grants from AstraZeneca, grants, and nonfinancial support from Goldfinch Bio, being a scientific co-founder and equity holder for Pensieve Health and a consultant for Variant Bio. GN reported being a scientific co-founder, consultant, advisory board member, and equity owner of Renalytix AI, a scientific co-founder and equity holder for Pensieve Health, a consultant for Variant Bio, and receiving grants from Goldfinch Bio and personal fees from Renalytix AI, BioVie, Reata, AstraZeneca, and GLG Consulting. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
: The Institutional Review Board of Mount Sinai approved the study.
: Not applicable. No individual participant data is reported.
Free to read: This content has been made available to all.